Altoona Arthritis & Osteoporosis Center, the Altoona Center for Clinical Research Participating in ORCA-3


Altoona Arthritis and Osteoporosis Center and the Altoona Center for Clinical Research is enrolling eligible volunteers into ORCA-3, a U.S. Phase 3 clinical research study evaluating the safety and efficacy of cytisinicline, an investigational therapy for smoking cessation. ORCA-3 is seeking to enroll adults who smoke 10 or more cigarettes per day, intend to quit smoking, and have failed at least one previous attempt to stop smoking with or without therapeutic support.

A recent report showed that in 2020, for the first time in 20 years, there was an increase in cigarette purchases. Despite...

For access to this article please sign in or subscribe.


Reader Comments(0)


Our Family of Publications Includes:


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2023

Rendered 09/19/2023 14:47